Immutep Limited (IMMP) — Analyst outlook / Analyst consensus target is. Based on 4 analyst ratings, the consensus is bullish — 2 Buy, 2 Hold.
The consensus price target is $4.25 (low: $3.50, high: $5.00), representing an upside of 681.3% from the current price $0.54.
Analysts estimate Earnings Per Share (EPS) of $-0.30 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.36 vs est $-0.30 (missed -18.4%). 2025: actual $-0.42 vs est $-0.41 (missed -3%). Analyst accuracy: 91%.
IMMP Stock — 12-Month Price Forecast
$4.25
▲ +681.25% Upside
Average Price Target
Based on 4 Wall Street analysts offering 12-month price targets for Immutep Limited, the average price target is $4.25, with a high forecast of $5.00, and a low forecast of $3.50.
The average price target represents a +681.25% change from the last price of $0.54.
Highest Price Target
$5.00
Average Price Target
$4.25
Lowest Price Target
$3.50
IMMP Analyst Ratings
Buy
Based on 4 analysts giving stock ratings to Immutep Limited in the past 3 months
EPS Estimates — IMMP
91%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$0.36
vs Est –$0.30
▼ 15.5% off
2025
Actual –$0.42
vs Est –$0.41
▼ 2.9% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — IMMP
64%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual $0.004B
vs Est $0.004B
▼ 12.0% off
2025
Actual $0.005B
vs Est $0.008B
▼ 60.9% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
